Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kangasmäki A[au]:

Radiotherapy Boost for the Dominant Intraprostatic Cancer Lesion-A Systematic Review and Meta-Analysis. von Eyben FE et al. Clin Genitourin Cancer. (2016)

Management of advanced prostate cancer. von Eyben F et al. Ann Oncol. (2015)

Imaging of Accidental Contamination by Fluorine-18 Solution: A Quick Troubleshooting Procedure. Kairemo K et al. Asia Ocean J Nucl Med Biol. (2016)

Search results

Items: 30

1.
2.

Multimodal Primary Treatment of Metastatic Prostate Cancer with Androgen Deprivation and Radiation.

Joensuu T, Joensuu G, Kairemo K, Kiljunen T, Riener M, Aaltonen A, Ala-Opas M, Kangasmäki A, Alanko T, Taipale L, Hervonen P, Bützow A, Virgolini I, Hemminki A.

Anticancer Res. 2016 Dec;36(12):6439-6447.

PMID:
27919966
3.

Imaging of Accidental Contamination by Fluorine-18 Solution: A Quick Troubleshooting Procedure.

Kairemo K, Kangasmäki A.

Asia Ocean J Nucl Med Biol. 2016 Winter;4(1):51-54.

4.

Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics.

Kairemo K, Joensuu T, Rasulova N, Kiljunen T, Kangasmäki A.

Diagnostics (Basel). 2015 Jul 30;5(3):358-68. doi: 10.3390/diagnostics5030358.

5.

Radiotherapy Boost for the Dominant Intraprostatic Cancer Lesion-A Systematic Review and Meta-Analysis.

von Eyben FE, Kiljunen T, Kangasmaki A, Kairemo K, von Eyben R, Joensuu T.

Clin Genitourin Cancer. 2016 Jun;14(3):189-97. doi: 10.1016/j.clgc.2015.12.005. Epub 2015 Dec 17. Review.

PMID:
26768965
6.

Volumetric Modulated Arc Therapy Planning For Primary Prostate Cancer With Selective Intraprostatic Boost Determined By (18) f-Choline PET-CT: In Regard to Kuang et al.

von Eyben FE, Kiljunen T, Kangasmaki A, Kairemo K, von Eyben R, Joensuu T.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):466-7. doi: 10.1016/j.ijrobp.2015.06.008. No abstract available.

PMID:
26383684
7.

Management of advanced prostate cancer.

von Eyben F, Kiljunen T, Kangasmaki A, Kairemo K, von Eyben R, Joensuu T.

Ann Oncol. 2015 Nov;26(11):2354. doi: 10.1093/annonc/mdv327. Epub 2015 Jul 27. No abstract available.

PMID:
26216387
8.

PET/CT Dose Planning for Volumetric Modulated Arc Radiation Therapy (VMAT) -Comparison with Conventional Approach in Advanced Prostate Cancer Patients.

Kairemo K, Rasulova N, Kiljunen T, Partanen K, Kangasmäki A, Joensuu T.

Curr Radiopharm. 2015;8(1):2-8.

PMID:
25882786
9.

VMAT technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases.

Kiljunen T, Kangasmäki A, Aaltonen A, Kairemo K, Partanen K, Joensuu G, Alanko T, Vaalavirta L, Joensuu T.

Acta Oncol. 2015 Jun;54(6):847-53. doi: 10.3109/0284186X.2014.962665. Epub 2014 Oct 13.

PMID:
25307406
10.

Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report.

von Eyben FE, Kangasmäki A, Kiljunen T, Joensuu T.

Tumori. 2013 May-Jun;99(3):e120-3. doi: 10.1700/1334.14819.

PMID:
24158080
11.

4D SPECT/CT acquisition for 3D dose calculation and dose planning in (177)Lu-peptide receptor radionuclide therapy: applications for clinical routine.

Kairemo K, Kangasmäki A.

Recent Results Cancer Res. 2013;194:537-50. doi: 10.1007/978-3-642-27994-2_31.

PMID:
22918781
12.

Comparison of in vitro breast cancer visibility in analyser-based computed tomography with histopathology, mammography, computed tomography and magnetic resonance imaging.

Keyriläinen J, Fernández M, Bravin A, Karjalainen-Lindsberg ML, Leidenius M, von Smitten K, Tenhunen M, Kangasmäki A, Sipilä P, Nemoz C, Virkkunen P, Suortti P.

J Synchrotron Radiat. 2011 Sep;18(Pt 5):689-96. doi: 10.1107/S090904951102810X. Epub 2011 Jul 26.

PMID:
21862846
13.

Sodium iodide symporter SPECT imaging of a patient treated with oncolytic adenovirus Ad5/3-Δ24-hNIS.

Rajecki M, Kangasmäki A, Laasonen L, Escutenaire S, Hakkarainen T, Haukka J, Ristimäki A, Kairemo K, Kangasniemi L, Kiljunen T, Joensuu T, Pesonen S, Hemminki A.

Mol Ther. 2011 Apr;19(4):629-31. doi: 10.1038/mt.2011.31. No abstract available.

14.

[Modern radiation therapy].

Kouri M, Kangasmäki A.

Duodecim. 2009;125(9):947-58. Review. Finnish.

PMID:
19517863
15.

Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.

Tenhunen M, Collan J, Kouri M, Kangasmäki A, Heikkonen J, Kairemo K, Mäkitie A, Joensuu H, Saarilahti K.

Radiother Oncol. 2008 May;87(2):260-7. doi: 10.1016/j.radonc.2008.02.017. Epub 2008 Mar 7.

PMID:
18329118
16.

Brain function during multi-trial learning in mild cognitive impairment: a PET activation study.

Moulin CJ, Laine M, Rinne JO, Kaasinen V, Sipilä H, Hiltunen J, Kangasmäki A.

Brain Res. 2007 Mar 9;1136(1):132-41. Epub 2007 Jan 2.

PMID:
17198694
17.

Erratum to "Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer" [Radiother. Oncol. 78 (2006) 270-275].

Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M.

Radiother Oncol. 2006 Jul;80(1):107-8. No abstract available.

PMID:
16972340
18.

Radiation exposure in body computed tomography examinations of trauma patients.

Kortesniemi M, Kiljunen T, Kangasmäki A.

Phys Med Biol. 2006 Jun 21;51(12):3269-82. Epub 2006 Jun 6.

PMID:
16757876
19.

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.

Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M.

Radiother Oncol. 2006 Mar;78(3):270-5. Epub 2006 Mar 27. Erratum in: Radiother Oncol. 2006 Jul;80(1):107-8.

PMID:
16564589
20.

1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.

Timonen M, Kankaanranta L, Lundbom N, Collan J, Kangasmäki A, Kortesniemi M, Häkkinen AM, Lönngren A, Karjalainen S, Rasilainen M, Leinonen J, Huitti T, Jääskeläinen J, Kouri M, Savolainen S, Heikkinen S.

Eur J Radiol. 2005 Nov;56(2):154-9.

PMID:
16233888
21.

Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging.

Perkiö J, Soinne L, Østergaard L, Helenius J, Kangasmäki A, Martinkauppi S, Salonen O, Savolainen S, Kaste M, Tatlisumak T, Aronen HJ.

Stroke. 2005 Jan;36(1):44-9. Epub 2004 Dec 2.

PMID:
15576655
22.

Localization of local anesthetic solution by magnetic resonance imaging.

Niemi-Murola L, Krootila K, Kivisaari R, Kangasmäki A, Kivisaari L, Maunuksela EL.

Ophthalmology. 2004 Feb;111(2):342-7.

PMID:
15019387
23.

Study of the relative dose-response of BANG-3 polymer gel dosimeters in epithermal neutron irradiation.

Uusi-Simola J, Savolainen S, Kangasmäki A, Heikkinen S, Perkiö J, Abo Ramadan U, Seppälä T, Karila J, Serén T, Kotiluoto P, Sorvari P, Auterinen I.

Phys Med Biol. 2003 Sep 7;48(17):2895-906.

PMID:
14516107
24.

1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T.

Heikkinen S, Kangasmäki A, Timonen M, Kankaanranta L, Häkkinen AM, Lundbom N, Vähätalo J, Savolainen S.

Phys Med Biol. 2003 Apr 21;48(8):1027-39.

PMID:
12741499
25.

Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging.

Perkiö J, Aronen HJ, Kangasmäki A, Liu Y, Karonen J, Savolainen S, Østergaard L.

Magn Reson Med. 2002 May;47(5):973-81.

26.

Non-linear model for the kinetics of 10B in blood after BPA-fructose complex infusion.

Ryynänen P, Kangasmäki A, Hiismäki P, Coderre J, Diaz AZ, Kallio M, Laakso J, Kulvik M, Savolainen S.

Phys Med Biol. 2002 Mar 7;47(5):737-45.

PMID:
11931468
27.

Diffusion-weighted MR imaging in normal human brains in various age groups.

Helenius J, Soinne L, Perkiö J, Salonen O, Kangasmäki A, Kaste M, Carano RA, Aronen HJ, Tatlisumak T.

AJNR Am J Neuroradiol. 2002 Feb;23(2):194-9.

28.

Short lifetimes in 28Al.

Kangasmäki A, Tikkanen P, Keinonen J.

Phys Rev C Nucl Phys. 1994 Sep;50(3):1370-1376. No abstract available.

PMID:
9969797
29.

Short lifetimes in 28Si.

Tikkanen P, Keinonen J, Kangasmäki A, Fülöp Z, Kiss ÁZ, Somorjai E.

Phys Rev C Nucl Phys. 1993 Jan;47(1):145-156. No abstract available.

PMID:
9968419
30.

Short lifetimes in mirror nuclei 25Mg-25Al.

Tikkanen P, Keinonen J, Kangasmäki A, Fülöp Z, Kiss ÁZ, Somorjai E.

Phys Rev C Nucl Phys. 1991 May;43(5):2162-2171. No abstract available.

PMID:
9967267

Supplemental Content

Loading ...
Support Center